Attention all new applicants
Beginning February 21, 2022, MSK will require all new hires, volunteers, and vendors who come onsite to provide proof of complete COVID-19 vaccination series + booster (once eligible) based on the vaccines' high level of protection and our shared responsibility in protecting our patients. Read more
Assistant or Associate Attending, Myeloma
LocationNew York, NY
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. We’re treating cancer, one patient at a time. Join us and make a difference every day.
MSK requires all new hires, volunteers, and vendors who come onsite to provide proof of COVID-19 vaccination. This is based on the COVID-19 vaccines’ high level of protection and our shared responsibility in protecting our patients.
Beginning on February 21, 2022, MSK will require all new hires, volunteers, and vendors who come onsite to provide proof of complete COVID-19 vaccination series + booster (once eligible). Individuals currently eligible for a COVID-19 booster must get their booster, or have an approved exemption as a condition of employment at MSK. Individuals can get their COVID-19 booster 5 months after receiving their second dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine, or 2 months after the Johnson & Johnson vaccine. Individuals who are not yet eligible for a booster must meet this criteria within 30 days of becoming eligible.
Assistant or Associate Attending, Myeloma – Department of Medicine
Memorial Sloan Kettering Cancer Center
*Applicants should hold a Doctor of Medicine, or equivalent, degree and be certified or board eligible in Medical Oncology*
Memorial Sloan Kettering Cancer Center (MSK) is one of the world’s premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.
The Myeloma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center is seeking full-time faculty members at the Assistant or Associate Attending level for clinical service, teaching, and research. Highly motivated and collaborative candidates with research interests in genomics and/or healthcare disparities are strongly encouraged to apply. Under new leadership, the Myeloma Service has a strong interest in delivering multidisciplinary care for patients with all myeloma entities and furthering a comprehensive research portfolio. Our 9 full-time oncologists see patients at different stages of their disease management, coordinating their care and developing comprehensive and innovative strategies using conventional and investigational treatments, including immune-based, targeted and cell therapies. The service supports a wide range of clinical and translational research, with established collaborations with other clinical services and research laboratories within MSK as well as external collaborators, and a strong track record of publications in top tier journals of medicine, oncology, and hematology. Candidates must be board certified or board eligible in medical oncology or hematology.
Please send CV, a letter outlining your interest and names/contact information of three references via email to:
Saad Z. Usmani, MD, MBA, FACP
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center firstname.lastname@example.org
cc: David Pagel, email@example.com
New York, NY
At MSK, we are committed to providing exceptional patient care that is as convenient as possible. Each of our facilities serves a purpose and is strategically built to support a larger community, including our employees.